This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Abbvie faces off with Dutch plaintiffs in Humira litigation

( May 15, 2024, 11:12 GMT | Official Statement) -- MLex Summary: The Pharmaceutical Accountability Foundation said it today appeared before a Dutch court to start the pursuit of millions of euros in damages from AbbVie, as part of a lawsuit over the pricing of arthritis drug Humira. It said the initial arguments related to procedural issues. AbbVie argues the Dutch court has no jurisdiction to hear the claim against because its main headquarters are in the USA.The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections